In a record year for venture capital financing, biotech's gathered a large share of the total financing and had a record year as an...

The already substantial collaboration between tech and medicine should be encouraged and financed post-pandemic to make conduct of...

With the annual reporting season upon us, it's time for public companies to reassess their risk factor disclosures, particularly in light...